Sort
82,697 grants matching “vaccine development”
NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES
$1,479,558Emory University · P01 · FY2001 · AI
Mechanisms and Enviromental Determinants of Rhinovirus Illness Severity
$1,479,483James E. Gern · University Of Wisconsin-Madison · U19 · FY2013 · AI
Immunology, virology, and epidemiology of flaviviruses and other emerging viruses
$1,479,310Leah Katzelnick · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
International Research in Cambodia: Tropical Medicine and Vector Research
$1,479,224Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
SPORE in Prostate Cancer
$1,478,967Samuel R Denmeade · Johns Hopkins University · P50 · FY2020 · CA
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV
$1,478,693University Of Pittsburgh At Pittsburgh · P01 · FY2002 · AI
UAB Center for AIDS Research (CFAR)
$1,478,597Renee A. Heffron · University Of Alabama At Birmingham · P30 · FY2023 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,478,000John Christian Victor · Path · U01 · FY2010 · IP
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
$1,477,970Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2020 · CA
San Francisco Bay Clinical Trials Unit (CTU)
$1,477,862Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2025 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,477,795Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Task V2: Clinical Sample Testing from Influenza Clinical Trials for HAI, MN and NA Activity
$1,477,780Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$1,477,712Arun R Risbud · National Aids Research Institute · UM1 · FY2012 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$1,477,304Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$1,477,130Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Seattle-Lausanne-Kampala CTU
$1,476,996Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · AI
Self-administered microneedle patches for influenza vaccines
$1,476,869Richard W Compans · Emory University · U01 · FY2010 · AI
North Carolina STI/TM Cooperative Research Center
$1,476,830Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U19 · FY2006 · AI
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,475,743Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Characterization and improvement of graft versus leukemia effects
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Immunobiology and immunotherapy of leukemia
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
CNH: Cooking Up Clean Air: Scaled-Up Air Quality and Health Impacts of Clean Cookstoves in Ghana
$1,475,000Christine Wiedinmyer · University Corporation For Atmospheric Res · · FY2012 · GEO
Poxvirus Modulation of Immune Responses
$1,474,724Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2004 · AI
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,474,679Paul Stephen Keim · Northern Arizona University · U19 · FY2024 · AI
Research to control and eliminate malaria in SE Asia and SW Pacific
$1,474,468James Walter Kazura · Case Western Reserve University · U19 · FY2016 · AI